SCHEMBL6665063

SCHEMBL6665063

CCc1c(C)cc(C)c(S(N)(=O)=O)c1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.43
CA2 P00918 8/20 0.40
CA1 P00915 7/20 0.40
CA7 P43166 7/20 0.40
CA13 Q8N1Q1 6/20 0.40
CA12 O43570 4/20 0.40
LMNA P02545 1/20 0.35
SLC11A2 P49281 1/20 0.34
PGK1 P00558 1/20 0.33
PGK2 P07205 1/20 0.33
RAPGEF4 Q8WZA2 2/20 0.32
CA4 P22748 5/20 0.32
CA6 P23280 4/20 0.32
CA9 Q16790 4/20 0.32
CA5B Q9Y2D0 4/20 0.32
CA3 P07451 1/20 0.32
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
GAA P10253 1/20 0.31
PDIA6 Q15084 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5321971 0.82 CA2 (0.44) RAB9ACA2CA1CA7CA13
SCHEMBL2932203 0.77 RAB9A (0.53) RAB9ACA2CA1CA7CA13
SCHEMBL30229578 0.76 NOS1 (0.39) RAB9ACA2CA1CA7CA13
SCHEMBL6586893 0.74 ALDH1A1 (0.48) RAB9ACA2CA1CA7CA13
SCHEMBL28166915 0.73 PGK1 (0.46) SLC11A2PGK1PGK2
SCHEMBL29106965 0.73 CA2 (0.35) CA2CA1CA7CA13CA12
SCHEMBL2933802 0.72 RAB9A (0.47) RAB9ACA2CA1CA7CA13
SCHEMBL21550397 0.72 TAAR1 (0.40) RAB9ACA2CA1CA7CA13
SCHEMBL21550420 0.71 PTGES2 (0.40) CA2CA1CA7CA13CA12
SCHEMBL20000078 0.69 ALDH1A1 (0.34) CA2CA1CA7CA13CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1453787-A1 CYCLOALKYL SUBSTITUTED POLYAMINES FOR CANCER THERAPY AND METHODS OF SYNTHESIS THEREFOR SLIL Biomedical Corporation (US) 2004-09-08 EP disclosed
WO-2003050072-A1 CYCLOALKYL SUBSTITUTED POLYAMINES FOR CANCER THERAPY AND METHODS OF SYNTHESIS THEREFOR SLIL BIOMEDICAL CORPORATION (US) 2003-06-19 WO disclosed